PRF1 and primary progressive multiple sclerosis: These major increase of the cytotoxic NK subset studied would be compatible with previous results reporting increased circulating cytCD56dim NK levels expressing perforin in primary progressive MS patients, a clinical form with men’ predominance (40), which might suggest a role of this NK cell subset in the pathophysiology and progression of the disease.